Table 1 Clinical characteristics and baseline ultrasound indicators between patients with and without residual neuromuscular blockade.

Female (%)

58.8

73.1

0.131

Age^a

36.4±11.5

41.4±10.2

0.065

ASA I (%)

73.5

65.9

0.616

Body mass index (kg/m^2)

22.95±3.82

23.58±3.01

0.429

Fentanyl dose^a (μg)

224.3±93.8

212.8±32.2

0.932

Rocuronium/weight^a (mg/kg)

0.71±0.15

0.74±0.13

0.239

Anaesthesia time^a (minute)

87.6±30.9

73.2±18.9

0.042

Pre-Thickening fraction^a

0.50±0.27

0.53±0.23

0.252

Pre-Diaphragm excursion (QB)

1.53±0.47

1.45±0.43

0.466

Pre-Diaphragm excursion (DB)

4.88±1.21

4.70±1.14

0.518

Pre-Diaphragm excursion fraction

0.32±0.10

0.32±0.09

0.821

Pre-Diaphragm excursion difference

3.35±1.11

3.25±1.04

0.684

O/AAS-extubation^a

1.2±0.4

1.5±0.5

0.155

TOFr at extubation

95.8±7.5

53.4±21.9

<0.001

Thickening fraction^a

0.44±0.22

0.34±0.18

0.039

Diaphragm excursion (QB)

1.48±0.56

1.46±0.52

0.868

Diaphragm excursion (DB)

4.11±0.97

2.89±1.37

<0.001

Diaphragm excursion fraction

0.36±0.12

0.56±0.19

<0.001

Diaphragm excursion difference

2.63±0.82

1.43±1.10

<0.001